Aurora Innovation, Inc. quarterly report, Q3 FY2021

Business context and reporting period

Aurora Innovation, Inc.’s Form 10-Q covers the quarter and nine months ended September 30, 2021. The financial statements primarily reflect Reinvent Technology Partners Y (RTPY), a SPAC formed to pursue a business combination—not Aurora’s operating business. RTPY reported no operating revenue or business operations before the transaction.

The Aurora business combination closed on November 3, 2021, after the reporting period. At closing, 77.196% of public shares were redeemed; the sponsor forfeited 17,434,414 shares. The company also completed a $1.0 billion PIPE investment for 100 million shares. These subsequent events are not reflected in the September 30 balance sheet.

Key financial metrics

  • Revenue and margins: No operating revenue; margins are not applicable.
  • Net loss: $0.39 million for Q3 2021 and $6.22 million for the first nine months of 2021. Q3 loss per share rounded to zero; nine-month loss per share was $0.05 for each share class.
  • Expenses and other income: General and administrative expenses were $7.19 million for Q3 and $8.20 million year to date. Other income was $6.80 million in Q3, mainly a $6.79 million gain from changes in warrant fair value; year-to-date other income was $1.98 million, including a $3.04 million warrant fair-value gain and $1.11 million of warrant financing costs.
  • Cash flow: For the first nine months, operating cash use was $1.97 million, investing cash use was $977.50 million (funds deposited in the trust), and financing cash provided was $979.73 million. Ending cash was $262,793.
  • Liquidity: Trust investments were $977.56 million at September 30. The company reported negative working capital of approximately $6.2 million and $7.60 million of current liabilities.
  • Debt and liabilities: No long-term debt was reported. Liabilities included $32.12 million of derivative warrant liabilities and $34.21 million of deferred underwriting commissions.

Changes, outlook, and risks

  • The filing presents 2021 results but no prior-year comparable operating results; a clear year-over-year comparison is therefore unavailable. The reported activity was mainly SPAC formation, IPO costs, and pursuit of the Aurora transaction.
  • Management provided no operating guidance. It expected higher public-company compliance and due-diligence costs. The filing states that substantially all trust funds were used to complete the combination and fund redemptions.
  • RTPY revised its presentation to classify all redeemable Class A shares as temporary equity. The revision reclassified $72.46 million from shareholders’ equity and did not affect total assets, total liabilities, cash flows, or net loss.
  • Six shareholder demand letters and one lawsuit alleged proxy-statement disclosure deficiencies and fiduciary-duty or securities-law violations related to the combination. The company said it believed the allegations were without merit.
  • Management noted that COVID-19 could adversely affect financial position, operations, or the search for a target, but the specific impact was not determinable. The previously identified internal-control material weakness was reported as remediated; management concluded disclosure controls were effective at quarter-end.

Investor facts to verify

  1. Review the November 3, 2021 business-combination closing disclosures, including redemption levels, PIPE proceeds, and final share count and capital structure.
  2. Confirm how the trust funds and transaction proceeds were applied and assess Aurora’s post-combination cash needs; this 10-Q does not provide Aurora operating results.
  3. Track the shareholder lawsuit and demand-letter matters, and review the company’s later filings for any material developments.
  4. Assess the warrant liability valuation and potential dilution from outstanding warrants and equity awards.